Non-Infectious Uveitis
Conditions
Interventions
None listed
Sponsors
Nishi Kazuhiko
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have the following criteria 1) and 2) are eligible. 1) The month in which the following two codes are first shown in the same month (the initial diagnosis month) exists after October 2016. i) Ophthalmology examination codes ii) Non-infectious uveitis-related disease codes 2) The observation start date on the dataset is before 6 months of the initial diagnosis month.
Exclusion criteria
Exclusion criteria: Patients who have either of the following 1) or 2) are excluded from the study. 1) Patients who are given disease codes related to infectious uveitis after the month of their initial diagnosis. 2) Patients who are not given any disease code related to non-infectious uveitis since the second month after the initial diagnosis month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number and percentage of patients in the no treatment group, the group treated only with steroid eye drops, and the group treated with treatment other than steroid eye drops will be calculated. The presence or absence of each treatment category is calculated, and the pattern is clarified by using a line list, Sankey diagram, etc. | — |
Secondary
| Measure | Time frame |
|---|---|
| Description of various summary statistics on background factors of the analysis population Analysis of the occurrence of glaucoma, cataract, and infection associated with treatment with steroids, biologics, and other drugs and their related factors | — |
Contacts
Public ContactTakashi Omoto
Chugai Pharmaceutical Co., Ltd.
Outcome results
None listed